Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery
Use of a wire to localize a non-palpable breast lesion for surgery is standard but archaic. We sought to evaluate a new radiofrequency localization system (RFLS) as an effective, non-radioactive alternative to the wire.
Patients who required surgical excision of a non-palpable breast lesion were consented for the study. Patients underwent localization with a radiofrequency Tag and surgical removal guided by the handheld LOCalizer probe. The primary study endpoint was successful placement and retrieval of the Tag, and secondary endpoints included marker migration; days prior to surgery of Tag insertion; patient, radiologist, and surgeon experience; distance of Tag from skin; and positive margin and re-excision rates for cancer.
Fifty patients had successful placement and retrieval of the radiofrequency Tag. Likert questionnaire data revealed that most patients thought the procedure went smoothly and was easier than expected. Radiologists and surgeons thought that the Tag was as reliable as the wire. Of the 33 patients who had surgery for in situ or invasive cancer, one had a positive margin on final pathology (3%) and two underwent re-excision (6%).
Data from this pilot study suggest that the RFLS is an effective localization system for non-palpable breast lesions intended for surgical removal. Unlike most other technologies, the LOCalizer probe detects distance from the Tag, and this unique feature may have contributed to the low positive margin rate seen in this study. The RFLS appears to offer advantages over current localization procedures and should be explored as an alternative to wire. ClinicalTrials.gov Identifier: NCT03202472.
KeywordsRadiofrequency Tag Breast surgery Wire-free localization
Radiofrequency identification localization system
Radioactive seed localization
Food and Drug Administration
Compliance with ethical standards
Conflict of interest
All the authors declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Leeming R, Madden M, Levy L (1993) An improved technique for needle localized biopsies of the breast. Surg Gynecol Obstet 177:84–86Google Scholar
- 3.Jones MK, Vetto JT, Pommier RF, Thurmond AS, Woltering EA (1994) An improved method of needle localized biopsy of nonpalpable lesions of the breast. J Am Coll Surg 178:548–552Google Scholar
- 8.Gray RJ, Salud C, Nguyen K, Dauway E, Friedland J, Berman C, Peltz E, Whitehead G, Cox CE (2001) Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol 8(9):711–715CrossRefGoogle Scholar
- 16.Jadeja PH, Mango V, Patel S, Friedlander L, Desperito E, Ayala-Bustamante E, Wynn R, Chen-Seetoo M, Taback B, Feldman S, Ha R (2018) Utilization of multiple SAVI SCOUT surgical guidance system reflectors in the same breast: a single-institution feasibility study. Breast J 24(4):531–534CrossRefGoogle Scholar
- 18.Cox CE, Russell S, Prowler V, Carter E, Beard A, Mehindru A, Blumencranz P, Allen K, Portillo M, Whitworth P, Funk K, Barone J, Norton D, Schroeder J, Police A, Lin E, Combs F, Schnabel F, Toth H, Lee J, Anglin B, Nguyen M, Canavan L, Laidley A, Warden MJ, Prati R, King J, Shivers SC (2016) A prospective, single arm, multi-site, clinical evaluation of a nonradioactive surgical guidance technology for the location of nonpalpable breast lesions during excision. Ann Surg Oncol 23(10):3168–3174CrossRefGoogle Scholar
- 20.Cox CE, Garcia-Henriquez N, Glancy MJ, Whitworth P, Cox JM, Themar-Geck M, Prati R, Jung M, Russell S, Appleton K, King J, Shivers SC (2016 Jun) Pilot study of a new nonradioactive surgical guidance technology for locating nonpalpable breast lesions. Ann Surg Oncol 23(6):1824–1830CrossRefGoogle Scholar